Merck dives into COPD treatments with $10 billion purchase of Verona Pharma
Verona Pharma’s stock soars toward a record after $10 billion buyout deal with Merck.
Why interest-rate cuts won’t be the fuel the stock market needs to rocket higher
There’s no consistent pattern to how the stock investors react when the Fed lowers rates.
Why this veteran advisor says it’s speculative not to have crypto in portfolios
Ric Edelman argues that the time to invest in cryptocurrencies is now, while 95% of the world is still asleep.
What will it take for the Fed to cut rates in September? Look here for clues.
Economists will be reading the minutes of the Federal Reserve’s June meeting to get a sense of what might have to happen in order for the central bank to cut interest rates in September.
Zuckerberg’s Meta reportedly takes stake in Ray-Ban maker, showing commitment to AI-powered smartglasses
Meta reportedly takes a 3% stake in EssilorLuxottica
When my friend was on her deathbed, her parents took $25,000 in cash and won’t give it to her son. Do we tell him?
“They are a very religious family. These are the same people who hug the altar every week.”